References Semaglutide Microdose (Compounded) Semaglutide Microdose is a lower-strength compounded formulation of the same active ingredient as standard semaglutide, designed to provide a gentler introduction for patients new to GLP-1 therapy or those who experienced side effects at standard doses
Medications such as Ozempic (semaglutide), Wegovy (semaglutide), Rybelsus (semaglutide), Mounjaro (tirzepatide), Zepbound (tirzepatide), Saxenda (liraglutide), IMCIVREE (setmelanotide), Qsymia (phentermine-topiramate), Adipex-P (phentermine), Lomaira (phentermine), Alli (orlistat), Xenical (orlistat), Contrave (naltrexone-bupropion), as well as other medications like antidepressants prescribed off-label
Use of glucagon-like peptide 1 receptor agonists and risk of serious renal events: Scandinavian cohort study
Necessary Medical Evaluations and Tests Your healthcare provider or doctor will conduct a physical exam during the medical evaluation